FDA Approves Treatment for Hemophilia A
August 31st 2018Officials with the FDA have approved Bayer’s antihemophilic factor [recombinant] PEGylated-aucl, BAY94-9027 (Jivi), for the routine prophylactic treatment of hemophilia A in previously treated adults and adolescents 12 years of age or older
Read More
FDA OKs New Treatment for Hemophilia A
August 30th 2018Officials with the FDA have approved Bayer’s antihemophilic factor [recombinant] PEGylated-aucl, BAY94-9027 (Jivi), for the routine prophylactic treatment of hemophilia A in previously treated adults and adolescents 12 years of age or older.
Read More
Serious Health Risks Linked to Foods Containing Liquid Nitrogen Added Immediately Before Consumption
August 30th 2018Food products prepared by adding liquid nitrogen at the point of sale, immediately before consumption, have the potential for serious injury, and the FDA is advising consumers to avoid eating, drinking, or handling these products.
Read More
Dozens of Drug Products Recalled Due to Microbial Contamination
August 29th 2018The pet products included in the recall—sold to both consumers and veterinary professionals—are marketed for a variety of uses, including urinary incontinence, anxiety, arthritis, and digestion relief.
Read More
CDC: More Adolescents Receiving HPV Vaccination, But Improvement Needed
August 29th 2018Recent data show that more adolescents are starting and completing the series of HPV vaccinations meant to prevent cervical cancer. Despite the incease in immunizations, some forms of cancers caused by HPV are rising.
Read More